Menu Close

UBS Clients Raise $650 Million for Biggest Yet Biotech Impact Fund

view original post

[unable to retrieve full-text content]The Oncology Impact Fund 2, run by biotechnology investment firm MPM Capital, has raised a total of $850 million, including the $650 million obtained from UBS clients. It will inv …